Navigation Links
Infants with Rare Genetic Disease Saved By Cord Blood Stem Cells

rns survived transplant, whereas only 43 percent of the symptomatic babies survived, the study showed.

While the child's age and symptom severity at the time of transplant are crucial to determining outcome, the source of stem cells is also important, said Kurtzberg.

Cord blood appears to provide a better and faster correction of enzyme deficiencies than does adult bone marrow, she said. Stem cells from cord blood travel to the brain more rapidly than stem cells from adult bone marrow, and cord blood stem cells repair deficiencies in both the central and peripheral nervous systems, said Kurtzberg.

Thus, disease progression stabilizes about 2 to 4 months earlier in patients who receive cord blood compared to those who receive adult bone marrow, and huge developmental milestones occur during that period of infancy, said Kurtzberg.

The ease of obtaining cord blood also makes it an excellent source of stem cells, she said. Cord blood is readily available because it is extracted from discarded placentas (afterbirth) following child birth. Adult bone marrow must be harvested from living donors through an invasive surgical procedure.

Finally, cord blood cells are less mature than adult bone marrow cells and thus do not need to perfectly match the patient's immune-related blood proteins, called antigens, said Kurtzberg. Only four of six cord blood "antigens" must match for a transplant to have a reasonable chance of success, whereas adult bone marrow requires a greater degree of matching antigens, she said.

As a result, a cord blood donor unit can be identified and obtained within a week, whereas a matching adult donor can takes months to locate and obtain if available at all, said Kurtzberg.

Similar benefits of cord blood were seen in an earlier Duke study of children with Hurler Syndrome, results of which were published in the May 6, 2004, issue of the New England Journal of Medicine. In that study, Kurtzberg's team
'"/>

Source:DukeHealth


Page: 1 2 3 4

Related biology news :

1. Infants With Rare Genetic Disease Saved by Cord Blood Stem Cells
2. Antiretroviral Therapy May Prevent HIV Transmission From Breastfeeding Mothers To Infants
3. Infants can organise visual information at just four months
4. Novel Asthma Study Shows Multiple Genetic Input Required; Single-gene Solution Shot Down
5. Genetically modified natural killer immune cells attack, kill leukemia cells
6. Ants Genetic Engineering Leads To Species Interdependency
7. Genetic Variation Visualization - From EMBL
8. Genetically modified rice in China benefits farmers health, study finds
9. Genetically Modified Natural Killer Immune Cells Attack, Kill Leukemia Cells
10. Genetic defects give the immune system the green light to attack the pancreas
11. Maine Researchers Find Exceptions to Old Rules of Genetic Inheritance
Post Your Comments:
Breaking Biology Technology:Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 2Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 3Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 4Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 5Neurocrine Announces Top-Line Results From 703 Study (Tulip PETAL Study) of Elagolix for Treatment of Endometriosis Pain 6Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 2Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 3Cumberland Pharmaceuticals Licenses Caldolor(R) (ibuprofen) Injection to DB Pharm Korea for Commercialization in South Korea 4Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 2Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 3Olympics 2016, World Cup 2014, But First – Adventus Brasil 2009 4